AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12604935 — intervention group
Group type: COMPARATOR
Intervention: Self-measured white-coat hypertension (WCH)
Number of subjects: 0
Study 10817726 — intervention group
Group type: EXPERIMENTAL
Intervention: AMD-3100 intravenous infusion at 10, 20, 40, or 80 microg/kg
Number of subjects: 12
Study 10817726 — intervention group
Group type: EXPERIMENTAL
Intervention: AMD-3100 subcutaneous injection at 40 or 80 microg/kg
Number of subjects: 12
Study 10817726 — intervention group
Group type: EXPERIMENTAL
Intervention: AMD-3100 oral dosing at 80 and 160 microg/kg
Number of subjects: 12
Study 10817726 — intervention group
Group type: EXPERIMENTAL
Intervention: AMD-3100 intravenous dose at 80 microg/kg
Number of subjects: 12
Study 10817726 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacokinetic parameters
Number of subjects: 12
Study 10817726 — intervention group
Group type: EXPERIMENTAL
Intervention: AMD-3100 intravenous dose
Number of subjects: 12
Study 8877991 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 0.10 mg
Number of subjects: 20
Study 8877991 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 0.05 mg
Number of subjects: 20
Study 8877991 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 0.10 mg and 0.05 mg
Number of subjects: 20
Study 8877991 — intervention group
Group type: EXPERIMENTAL
Intervention: Responder patients
Number of subjects: 20
Study 1839442 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg once daily)
Number of subjects: 100
Study 1839442 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem (30 mg three times daily)
Number of subjects: 100
Study 6601279 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the right quadriceps femoris muscle (n = 20)
Number of subjects: 58
Study 6601279 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric strengthening of the quadriceps femoris muscle (n = 19)
Number of subjects: 58
Study 6601279 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 58
Study 28233481 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative infection group (N=52)
Number of subjects: 126
Study 28233481 — intervention group
Group type: COMPARATOR
Intervention: Non-infected group (N=74)
Number of subjects: 126
Study 28233481 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (infected and non-infected)
Number of subjects: 126
Study 29291429 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytosterols (PS, 2 g/d)
Number of subjects: 70
Study 29291429 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (CC, 200 mg/d)
Number of subjects: 70
Study 29291429 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PS and Curcumin (PS-CC, 2 g/d-200 mg/d)
Number of subjects: 70
Study 29291429 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL, no phytosterols or curcumin)
Number of subjects: 70
Study 25059838 — intervention group
Group type: COMPARATOR
Intervention: Iron supplementation
Number of subjects: 737
Study 25059838 — intervention group
Group type: COMPARATOR
Intervention: Micronutrient supplement
Number of subjects: 737
Study 25059838 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-iron groups
Number of subjects: 737
Study 25059838 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron and multiple micronutrient supplementation
Number of subjects: 737
Study 23474741 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + aPDT
Number of subjects: 30
Study 23474741 — intervention group
Group type: COMPARATOR
Intervention: SRP
Number of subjects: 30
Study 22943820 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 55
Study 19882739 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy for weight gain prevention (IPT-WG)
Number of subjects: 38
Study 19882739 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care health education group
Number of subjects: 38
Study 17336785 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagining eating a slice of chocolate cake while performing a simple reaction time task
Number of subjects: 58
Study 17336785 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagining drinking a glass of water while performing a simple reaction time task
Number of subjects: 58
Study 17336785 — intervention group
Group type: COMPARATOR
Intervention: Post-task consumption information (consumption vs no consumption)
Number of subjects: 58
Study 15801937 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo
Number of subjects: 12
Study 15801937 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger
Number of subjects: 12
Study 15801937 — intervention group
Group type: COMPARATOR
Intervention: Warfarin alone
Number of subjects: 12
Study 12635796 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load muscular training with moderate restriction of blood flow (group R, n = 22)
Number of subjects: 44
Study 12635796 — intervention group
Group type: COMPARATOR
Intervention: Low-load muscular training with moderate restriction of blood flow (group R, n = 8)
Number of subjects: 44
Study 12635796 — intervention group
Group type: COMPARATOR
Intervention: Training without restriction (group N, n = 22)
Number of subjects: 44
Study 10227417 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovations in informed consent methods
Number of subjects: 0
Study 10227417 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 8703997 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke-free policy program
Number of subjects: 155
Study 8703997 — intervention group
Group type: COMPARATOR
Intervention: Non smoke-free policy program
Number of subjects: 155
Study 2071257 — intervention group
Group type: EXPERIMENTAL
Intervention: L-alpha-glycerylphosphorylcholine (L-alpha-GFC)
Number of subjects: 32
Study 2071257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 2071257 — intervention group
Group type: COMPARATOR
Intervention: Scopolamine
Number of subjects: 32
Study 6395907 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG biofeedback (visual and auditory EMG training)
Number of subjects: 30
Study 6395907 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation treatment (modified PMR and imagery exercises)
Number of subjects: 30
Study 6395907 — intervention group
Group type: COMPARATOR
Intervention: Control group (stretching exercises)
Number of subjects: 30
Study 29661902 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.45 mg/d oral conjugated equine estrogen (oCEE)
Number of subjects: 75
Study 29661902 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 μg/d transdermal 17β‐estradiol (tE2)
Number of subjects: 75
Study 29661902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 26171861 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 grams of oral creatine/day
Number of subjects: 1741
Study 23635615 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific ambulation goals
Number of subjects: 146
Study 23635615 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 146
Study 23635615 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery
Number of subjects: 146
Study 23635615 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparotomy
Number of subjects: 146
Study 20666269 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with amlodipine and fosinopril given in the morning and at bedtime (group A)
Number of subjects: 40
Study 20666269 — intervention group
Group type: COMPARATOR
Intervention: Concomitant administration of amlodipine and fosinopril in the morning (group B)
Number of subjects: 40
Study 18789680 — intervention group
Group type: EXPERIMENTAL
Intervention: Berberine plus radiation therapy
Number of subjects: 90
Study 18789680 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus radiation therapy
Number of subjects: 90
Study 18076248 — intervention group
Group type: EXPERIMENTAL
Intervention: Velocity-spectrum training of the hip (8 training sessions over 4 weeks, unilateral hip flexion/extension and hip abduction/adduction, starting at 60 degrees x sec(‐1) and increasing to 180, 300, and 400 degrees x s(‐1))
Number of subjects: 23
Study 18076248 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained regular activity throughout the 4-week span)
Number of subjects: 23
Study 12663231 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol 500 mg daily for 6 months
Number of subjects: 30
Study 12663231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11115310 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone reminder group
Number of subjects: 264
Study 11115310 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail reminder group
Number of subjects: 264
Study 11115310 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential mail/telephone reminder group
Number of subjects: 264
Study 11115310 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 264
Study 8814628 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubricated dowels
Number of subjects: 0
Study 8814628 — intervention group
Group type: COMPARATOR
Intervention: Non-lubricated dowels
Number of subjects: 0
Study 1465591 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin (active drug)
Number of subjects: 60
Study 1465591 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 60
Study 6437343 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative administration of FT‐207 suppository (Group A)
Number of subjects: 72
Study 6437343 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative administration of FT‐207 suppository (Group B)
Number of subjects: 72
Study 31513262 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a Cilioretinal Artery (CRA) in fellow eyes without baseline CNV
Number of subjects: 350
Study 31513262 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a Cilioretinal Artery (CRA) in study eyes with baseline CNV
Number of subjects: 350
Study 29684647 — intervention group
Group type: EXPERIMENTAL
Intervention: BATHE intervention (Background, Affect, Trouble, Handling, Empathy) used by trained GPs
Number of subjects: 21
Study 29684647 — intervention group
Group type: EXPERIMENTAL
Intervention: Top-up trainings based on CA analysis
Number of subjects: 21
Study 29684647 — intervention group
Group type: EXPERIMENTAL
Intervention: CA methods for assessing implementation fidelity
Number of subjects: 21
Study 26709596 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-release (MR) formulations of omecamtiv mecarbil (25 mg)
Number of subjects: 65
Study 26709596 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release (IR) formulation of omecamtiv mecarbil (25 mg)
Number of subjects: 65
Study 24828092 — intervention group
Group type: COMPARATOR
Intervention: Conventional subunit vaccine (Agrippal S1; Novartis)
Number of subjects: 335
Study 24828092 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted vaccine (Fluad; Novartis)
Number of subjects: 335
Study 24828092 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccine (IDflu15; Sanofi Pasteur)
Number of subjects: 335
Study 24828092 — intervention group
Group type: COMPARATOR
Intervention: Conventional subunit vaccine
Number of subjects: 335
Study 24828092 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted vaccine
Number of subjects: 335
Study 24828092 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccine
Number of subjects: 335
Study 22183975 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive treatment (methotrexate 0.5 mg/kg/week, etanercept 0.8 mg/kg/week, prednisolone 0.5 mg/kg/day tapered to 0 by 17 weeks)
Number of subjects: 85
Study 22183975 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (same dosage as arm 1), etanercept placebo, and prednisolone placebo
Number of subjects: 85
Study 20573974 — intervention group
Group type: EXPERIMENTAL
Intervention: Congruent condition (ipsilateral response)
Number of subjects: 0
Study 20573974 — intervention group
Group type: EXPERIMENTAL
Intervention: Incongruent condition (contralateral response)
Number of subjects: 0
Study 17760981 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised physiotherapy treatment of advice and exercises for the arm and shoulder for three months
Number of subjects: 30
Study 17760981 — intervention group
Group type: COMPARATOR
Intervention: Leaflet containing advice and exercises (Control)
Number of subjects: 30
Study 17760981 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised physiotherapy treatment
Number of subjects: 30
Study 15013248 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion SR 300 mg/day
Number of subjects: 19
Study 15013248 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study 12146772 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained Achilles tendon stretches (3 minutes, 3 times daily)
Number of subjects: 94
Study 12146772 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Achilles tendon stretches (5 sets, 20 seconds each, 2 times daily)
Number of subjects: 94
Study 9659323 — intervention group
Group type: EXPERIMENTAL
Intervention: Casualty officers interpreting images
Number of subjects: 25
Study 9659323 — intervention group
Group type: COMPARATOR
Intervention: Radiology specialist registrars interpreting images
Number of subjects: 25
Study 8608441 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5 mg
Number of subjects: 18
Study 8608441 — intervention group
Group type: COMPARATOR
Intervention: Inactive placebo
Number of subjects: 18
Study 2773843 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iron therapy
Number of subjects: 196
Study 2773843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 2773843 — intervention group
Group type: EXPERIMENTAL
Intervention: Anemic infants
Number of subjects: 196
Study 2773843 — intervention group
Group type: COMPARATOR
Intervention: Control infants and nonanemic, iron-deficient infants
Number of subjects: 196
Study 2773843 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron deficiency progressing to anemia
Number of subjects: 196
Study 1035149 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tetracycline in combination with a topical sodium sulfacetamide-sulfur-hydro-cortisone lotion
Number of subjects: 95
Study 1035149 — intervention group
Group type: COMPARATOR
Intervention: Control group of 50 patients
Number of subjects: 95
Study 31662210 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for completing secondary prevention sessions
Number of subjects: 130
Study 31662210 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study 28686772 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (20 U total in affected area)
Number of subjects: 9
Study 28686772 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 9
Study 25395384 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 144
Study 25395384 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 144
Study 23861993 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (4 g/day for 12 months)
Number of subjects: 50
Study 23861993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 21287196 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength trained individuals (L(opt) 9.7% BW)
Number of subjects: 40
Study 21287196 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed trained individuals (L(opt) 9.2% BW)
Number of subjects: 40
Study 21287196 — intervention group
Group type: EXPERIMENTAL
Intervention: Physically active individuals (L(opt) 8.7% BW)
Number of subjects: 40
Study 21287196 — intervention group
Group type: COMPARATOR
Intervention: Sedentary individuals (L(opt) 8.0% BW)
Number of subjects: 40
Study 19718745 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous EMG monitoring plus visual facial observation (EMG group)
Number of subjects: 96
Study 19718745 — intervention group
Group type: COMPARATOR
Intervention: Visual facial observation only (control group)
Number of subjects: 96
Study 17451642 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) for CFS
Number of subjects: 128
Study 15483071 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g high‐isoflavone soy protein (SOY)
Number of subjects: 13
Study 15483071 — intervention group
Group type: COMPARATOR
Intervention: Control diet (meat protein)
Number of subjects: 13
Study 11666130 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin calcium followed by adjunctive oral aspirin for 6 months
Number of subjects: 172
Study 11666130 — intervention group
Group type: COMPARATOR
Intervention: Full heparinization
Number of subjects: 172
Study 9639862 — intervention group
Group type: EXPERIMENTAL
Intervention: Thinking about gender group's privileges
Number of subjects: 0
Study 9639862 — intervention group
Group type: EXPERIMENTAL
Intervention: Thinking about gender group's disadvantages
Number of subjects: 0
Study 8205854 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0
Study 8205854 — intervention group
Group type: COMPARATOR
Intervention: Control (no amiodarone)
Number of subjects: 0
Study 2531901 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ramipril once daily for 7 days
Number of subjects: 8
Study 2531901 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for 7 days
Number of subjects: 8
Study 31909554 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 g/l PEG (drought stress)
Number of subjects: 2
Study 31909554 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment (control)
Number of subjects: 2
Study 30993601 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Moms Training (MMT) for 8 weeks
Number of subjects: 220
Study 30993601 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 220
Study 28012633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (4mg/ml, 1ml) administered 15min before surgery
Number of subjects: 90
Study 28012633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (4mg/ml, 1ml) administered 15min after surgery
Number of subjects: 90
Study 28012633 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered 15min before and after surgery
Number of subjects: 90
Study 24555998 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV envelope‐expressing DNA vaccine (5 intramuscular injections at weeks 0, 8, 16, 40, and 44)
Number of subjects: 70
Study 24555998 — intervention group
Group type: COMPARATOR
Intervention: No vaccine (control group)
Number of subjects: 70
Study 24555998 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV envelope‐expressing DNA vaccine
Number of subjects: 70
Study 23212717 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive diabetes mellitus treatment
Number of subjects: 1015
Study 23212717 — intervention group
Group type: COMPARATOR
Intervention: Conventional diabetes mellitus treatment
Number of subjects: 1015
Study 22048910 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive training and help offered during BMT
Number of subjects: 999
Study 22048910 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 999
Study 19358927 — intervention group
Group type: EXPERIMENTAL
Intervention: crocetin (15 mg)
Number of subjects: 14
Study 19358927 — intervention group
Group type: EXPERIMENTAL
Intervention: ascorbic acid (3,000 mg)
Number of subjects: 14
Study 19358927 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study 16515100 — intervention group
Group type: EXPERIMENTAL
Intervention: OEFRP (orthodontic extrusion combined with fiberotomy and root planing)
Number of subjects: 20
Study 16515100 — intervention group
Group type: COMPARATOR
Intervention: OE (orthodontic extrusion)
Number of subjects: 20
Study 12625392 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-assisted closure
Number of subjects: 22
Study 12625392 — intervention group
Group type: COMPARATOR
Intervention: Traditional wet-to-dry/wet-to-wet technique
Number of subjects: 22
Study 12625392 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 22
Study 12585168 — intervention group
Group type: EXPERIMENTAL
Intervention: Colquhounia root tablet (CRT)
Number of subjects: 96
Study 12585168 — intervention group
Group type: COMPARATOR
Intervention: Hormone or cytotoxic medicine (Control)
Number of subjects: 96
Study 9584030 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of methadone with 5 visits per week
Number of subjects: 150
Study 9584030 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of methadone with fewer visits
Number of subjects: 150
Study 9584030 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg of methadone
Number of subjects: 150
Study 9584030 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 visits per week
Number of subjects: 150
Study 9584030 — intervention group
Group type: COMPARATOR
Intervention: 2 visits per week
Number of subjects: 150
Study 9584030 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall HIV infection rate at entry
Number of subjects: 150
Study 9584030 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk behaviors for AIDS
Number of subjects: 150
Study 7624397 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine and human epidermal growth factor
Number of subjects: 17
Study 7624397 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine (control)
Number of subjects: 17
Study 2647605 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of porcine GIP (2 pmol.kg‐1.min‐1)
Number of subjects: 0
Study 2647605 — intervention group
Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 0
Study 352210 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated bivalent (A/NJ and A/Victoria) influenza vaccine
Number of subjects: 40
Study 352210 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study 31402745 — intervention group
Group type: EXPERIMENTAL
Intervention: Relational savoring intervention
Number of subjects: 63
Study 31402745 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 63
Study 31179779 — intervention group
Group type: EXPERIMENTAL
Intervention: FMX101 4%
Number of subjects: 363
Study 31179779 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 363